Third Harmonic Bio, Inc.
THRD
$5.15
$0.000.00%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 6.07M | 5.90M | 5.73M | 5.68M | 5.06M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 16.72M | 16.44M | 17.07M | 14.07M | 11.29M |
Operating Income | -16.72M | -16.44M | -17.07M | -14.07M | -11.29M |
Income Before Tax | -15.83M | -13.11M | -13.80M | -10.71M | -7.86M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -15.83M | -13.11M | -13.80M | -10.71M | -7.86M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -15.83M | -13.11M | -13.80M | -10.71M | -7.86M |
EBIT | -16.72M | -16.44M | -17.07M | -14.07M | -11.29M |
EBITDA | -16.70M | -16.43M | -17.06M | -14.06M | -11.28M |
EPS Basic | -0.35 | -0.29 | -0.33 | -0.26 | -0.20 |
Normalized Basic EPS | -0.19 | -0.18 | -0.21 | -0.17 | -0.12 |
EPS Diluted | -0.35 | -0.29 | -0.33 | -0.26 | -0.20 |
Normalized Diluted EPS | -0.19 | -0.18 | -0.21 | -0.17 | -0.12 |
Average Basic Shares Outstanding | 44.92M | 44.83M | 41.32M | 40.56M | 40.21M |
Average Diluted Shares Outstanding | 44.92M | 44.83M | 41.32M | 40.56M | 40.21M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |